Cardiac fibrosis in mice with hypertrophic cardiomyopathy is mediated by non-myocyte proliferation and requires Tgf-β
Polakit Teekakirikul(Brigham and Women's Hospital), Jonathan G. Seidman(Harvard University), Russell A. Norris(Medical University of South Carolina), Ronny Alcalai(Harvard University), Andrew M. Tager(Harvard University), Okan Toka(Harvard University), Cordula M. Wolf(Friedrich-Alexander-Universität Erlangen-Nürnberg), Matthew Nayor(Boston University), Hiroko Wakimoto(Brigham and Women's Hospital), Roger R. Markwald(Medical University of South Carolina), Seda Eminaga(Yale University), Jeffery D. Molkentin(Cincinnati Children's Hospital Medical Center), Joachim P. Schmitt(Howard Hughes Medical Institute), Jae Bum Kim(Lehigh University), Libin Wang(Ningxia Medical University), Tetsuo Konno(Harvard University), Joshua Gorham(Harvard University), Stanley R. Hoffman(Medical University of South Carolina), Christine E. Seidman(Harvard University)
Cited by 438
Related Papers
Contemporary Definitions and Classification of the Cardiomyopathies
|Circulation|2006|3.4k
Fulminant Myocarditis with Combination Immune Checkpoint Blockade
|New England Journal of Medicine|2016|2.3k
2011 ACCF/AHA Guideline for the Diagnosis and Treatment of Hypertrophic Cardiomyopathy
|Circulation|2011|2.1k
Cells of the adult human heart
|Nature|2020|1.8k
American College of Cardiology/European Society of Cardiology Clinical Expert Consensus Document on Hypertrophic Cardiomyopathy
|Journal of the American College of Cardiology|2003|1.6k